Taken together, these findings show that the cysts generated from the cholangiocyte monolayer population do show a measurable CFTR-mediated swelling response and therefore can be used together with the FLIPR assay to assess the efficacy of new CFTR modulators designed to treat CF. The gene discussed is CFTR; the disease is cystic fibrosis.